Interval Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
45,591
+16,026
+54% +$4.43M 0.26% 118
2026
Q1
$8.73M Sell
29,565
-5,281
-15% -$1.57M 0.23% 112
2025
Q4
$9.52M Buy
34,846
+18,972
+120% +$5.16M 0.17% 147
2025
Q3
$4.29M Buy
+15,874
New +$4.32M 0.07% 239
2025
Q2
Sell
-22,820
Closed -$6.05M 381
2025
Q1
$6.05M Sell
22,820
-30,430
-57% -$7.51M 0.13% 147
2024
Q4
$12.4M Buy
53,250
+1,939
+4% +$446K 0.24% 96
2024
Q3
$11.3M Buy
51,311
+24,654
+92% +$5.1M 0.25% 97
2024
Q2
$5.24M Sell
26,657
-9,468
-26% -$1.96M 0.11% 188
2024
Q1
$7.78M Buy
+36,125
New +$7.59M 0.22% 131
2023
Q2
Sell
-40,079
Closed -$7.68M 271
2023
Q1
$7.68M Buy
40,079
+11,793
+42% +$2.13M 0.3% 89
2022
Q4
$4.76M Buy
+28,286
New +$4.92M 0.28% 104
2021
Q1
Sell
-8,374
Closed -$1.52M 265
2020
Q4
$1.52M Sell
8,374
-6,174
-42% -$1.05M 0.06% 182
2020
Q3
$2.43M Buy
+14,548
New +$2.45M 0.14% 153
2019
Q4
Sell
-10,500
Closed -$2.22M 214
2019
Q3
$2.22M Buy
+10,500
New +$2.19M 0.09% 171
2019
Q2
Sell
-56,250
Closed -$9.26M 202
2019
Q1
$9.26M Buy
+56,250
New +$9.94M 0.35% 75
2018
Q2
Sell
-14,100
Closed -$2.28M 206
2018
Q1
$2.28M Buy
+14,100
New +$2.24M 0.1% 172
2017
Q4
Sell
-13,924
Closed -$1.89M 186
2017
Q3
$1.89M Sell
13,924
-81,172
-85% -$10.3M 0.09% 152
2017
Q2
$11.9M Buy
+95,096
New +$11.4M 0.52% 61
2017
Q1
Sell
-48,200
Closed -$5.56M 181
2016
Q4
$5.56M Buy
+48,200
New +$5.36M 0.34% 88
2016
Q3
Sell
-90,542
Closed -$8.82M 161
2016
Q2
$8.82M Buy
90,542
+53,897
+147% +$5.09M 0.6% 49
2016
Q1
$3.52M Sell
36,645
-2,955
-7% -$269K 0.3% 90
2015
Q4
$3.59M Buy
+39,600
New +$3.73M 0.34% 76
2015
Q3
Sell
-28,441
Closed -$2.65M 150
2015
Q2
$2.65M Buy
+28,441
New +$2.65M 0.28% 79
2015
Q1
Sell
-14,000
Closed -$1.24M 143
2014
Q4
$1.24M Buy
+14,000
New +$1.19M 0.19% 95

Other funds holding CME

Interval Partners's CME Position: Q2 2026 in Review

Interval Partners increased its CME Group (CME) stake by 54% in Q2 2026, buying an estimated $4.43M and bringing the position to 45,591 shares worth $10.1M. The position accounts for 0.26% of the portfolio, ranked #118.

Interval Partners first reported a position in CME in Q4 2014 and has held it in 24 quarters since. The position peaked at $12.4M in Q4 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Interval Partners held 45,591 shares of CME Group worth $10.1M as of Q2 2026.
  • Interval Partners bought 16,026 CME Group shares in Q2 2026, an estimated $4.43M.
  • CME Group made up 0.26% of Interval Partners's portfolio in Q2 2026, its #118 holding.
  • Interval Partners first reported a position in CME Group in Q4 2014 and has held it in 24 quarters since.
  • Interval Partners's CME Group position peaked at $12.4M in Q4 2024.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Interval Partners's 13F filing for Q2 2026, filed 14 Aug 2026.